About Us


Our vision is to be one of the top Twenty Egyptian pharmaceutical companies by 2020 and one of the top thirty pharmaceutical companies in the Middle East by 2030.


Our mission is to make the Egyptian & Arabian people`s life better through our high quality manufactured products & moreover introducing products that add more value to the pharmaceutical market and more benefits to our customers.

Core values

EGPI Pharmaceuticals is committed to “making quality healthcare an affordable and accessible reality throughout the world.
To achieve this commitment, we have established ten core values that provide the foundations for all of our products and services.


We take care to deliver rigorous management of quality throughout all processes to ensure that appropriate standards are maintained until the final product is received and beyond Quality is ingrained in the work of our colleagues and all our Values. We are dedicated to the delivery of quality health care around the world. Our business practices and processes are designed to achieve quality results that exceed the expectations of all our stakeholders.

2-Customer Care

With excellence the goal of everything we do, we bring our insight and experience to adapt to each customer’s requirements and situation. Our aim throughout is customer satisfaction.


We are committed to offer cost effective solutions by having a thorough understanding of each market and its requirements.


We are committed to offering a wide range of products to allow our customers to confidently procure from a single reliable source.


Our logistics solutions are tailored to our customers’ specific needs and we work closely with our customers to ensure accurate and on-time delivery wherever in the world you are.


We are committed to building long-term relationships with all business partners for mutual benefit.


We pride ourselves on ethical working practices, backed by robust corporate and social responsibility that covers all of our dealings with customers, suppliers, employees and the environment.

8-Respect for People

We recognize that people are the cornerstone of EGPI success. We value our diversity as a source of strength and are proud of EGPI history of treating employees with respect and dignity.


We know that to be a successful company we must work together, transcending organizational and geographic boundaries to meet the changing needs of our customers.


Innovations is the key to improving health and sustaining EGPI growth and profitability

EGPI History

EGPI is a Pharmaceutical Manufacturing Company founded in 2006 (as a brother company of EGD= Egyptian Group for Drug Trading company which founded in1994 as a marketing company) to formulate, register and produce, high quality pharmaceutical products, initially focusing on the Egyptian market, but with a vision of expanding in Middle East.
EGPI is extending warm hands to receive knowledge, know how, and licenses, in order to use our powerful production, and marketing, capabilities in the Middle East for mutual benefit.
The state of-the-art EGPI Research & Development Department is the key of our success. It is equipped with advanced research technologies, information resources and databases, and is staffed with experienced, highly qualified pharmacists and chemists, allowing us to enrich our portfolio.
Currently EGPI has an extensive portfolio of more than 150 products covering a wide range of therapeutic categories.
EGPI departments are 10 which are enriched with more than 450 loyal employees


Thank you for taking the time to visit us on our website.
EGPI Pharmaceutical Company is one of the largest and most recognized pharmaceutical company in Egypt that manufactures, markets and distributes branded generics of human health products. Since its incorporation, EGPI strategy has been focused on creating a strong pharmaceutical industry that provides quality medicines to its patients and the communities in which it serves.
The EGPI Pharmaceutical Industry is committed to give relentless efforts to abide by the ethics and principles and comply with the rules and regulations of medicines manufacturing, administration in all aspects, marketing and production of quality medication by utilization of technological advancement and new inventions with the great objective of welfare of human beings in the therapeutic field.
The management of the Company has been able to continue smooth production process by successful dealing of the various significant issues such as efficient management of capital, due settlement of the institutional investment, proper sourcing and utilization and storing of required raw materials.
In the recent years new sophisticated medicine have been added with the product portfolio of the EGPI production capacity increased and marketing territory of the ُEGPI in both local and abroad expanded This is the mark of our gradual growth and preserving the interest of the investors through in accomplishment of our strategic objective.
In order to keep on our development and long term strategic goal, the Company is vigilant in respect of research and development, enhancement of production capacity, quality improvement of factory and registration of more medicine in the global market.

Keeping in view of growing market demand, medicine production capacity had been enhanced, some sophisticated modern machineries with required technologies had been added and to ensure the quality of production, experienced and dedicated personnel have been recruited.
Number of recent medicines have been marketed by which could earn the confidence of physicians and customers. In the year 2016, the sales growth of the was encouraging as compared to the previous year.
Looking ahead we are determined to achieve our goal of becoming a force in affordable, niche healthcare solutions. And to do this we will continue to capitalize and build on the unique fundamentals of our group values, people and products by encouraging innovation, entrepreneurship and growth.

The Board of Directors acknowledges the importance of the recommendations and suggestions of the shareholders and considers the same as a key driving force in attainment of the success and progress.

In conclusion, I would like to extend my profound thanks and appreciation to the EGYPT Government and regional health authorities and professionals as Special appreciation goes to all staff of EGPI for their loyalty and great contribution to our success through the years.

EGPI Board Of Directors

EGPI Board of Directors is the governing body of the Company, and is responsible for setting-up the general direction of the Company’s strategy, its vision and mission and reports to the shareholders of the Company on all aspects of the business.

The Board comprises of the five members.

Dr. Youssef Badran

Chairman and CEO

Dr. Mohamed Elbarbary

Vice President and CEO

Dr. Niazy Abdelghaffar

Vice President and CEO

Dr. Tarek Omar

Vice President and CEO

Dr. Ayman Gomaa

Vice President and CEO